The Value of Pimecrolimus in Improving Quality of Life of Children With Severe Eczema - An Open Non-Randomised Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2008.12.1095
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Improving Cardiovascular Health and Quality of Life in People With Severe Mental Illness: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2018English

Improving Value for Patients With Eczema

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Omega-3 Fatty Acids and Quality of Life in Psoriasis: An Open, Randomised Controlled Study

Our Dermatology Online
2019English

P19 - Assessment of Quality of Life in Uruguayan Children With Atopic Eczema and Their Families

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Different Potencies of Topical Corticosteroids for a Better Treatment Strategy in Children With Atopic Dermatitis (The Rotterdam Eczema Study): Protocol for an Observational Cohort Study With an Embedded Randomised Open-Label Controlled Trial

BMJ Open
Medicine
2019English

Chinese Herbal Medicine Granules (PTQX) for Children With Moderate to Severe Atopic Eczema: Study Protocol for a Randomised Controlled Trial

Trials
MedicinePharmacology
2015English

Approaches of Improving Food Allergy Knowledge: Children With Food Allergy’s Quality of Life

Environment-Behaviour Proceedings Journal
2018English

Health-Related Quality of Life From the Perspective of Children With Severe Specific Language Impairment

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2015English

Study Protocol: Efficacy of Oral Alitretinoin Versus Oral Cyclosporine a in Patients With Severe Recurrent Vesicular Hand Eczema (ALICsA): A Randomised Prospective Open-Label Trial With Blinded Outcome Assessment

BMJ Open
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy